CareLit · DOI-Nachweis · Endoskopie heute
Is there a difference in survival after photodynamic therapy of bile duct cancer depending on the sensitizer?
DOI 10.1055/s-2008-1061289
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Dechêne, E Maldonado-Lopez, P Hilgard, G Gerken, T Zöpf
ZeitschriftEndoskopie heute
Ausgabe02/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Photodynamic therapy (PDT) has shown significant survival benefit in non-resectable bile duct cancer. Two different hematoporphyrin derivatives (HPD) are today in clinical use as photosensitizers, Photofrin II (PF2) and Photosan-3 (PS3). Apart from their variations in chemical structure, little is known about potential differences in clinical performance. We retrospectively evaluated the effectiveness…
Zitieren
Zitierempfehlung
A Dechêne, E Maldonado-Lopez, P Hilgard, G Gerken, T Zöpf (2008) Is there a difference in survival after photodynamic therapy of bile duct cancer depending on the sensitizer?. Endoskopie heute (02). https://doi.org/10.1055/s-2008-1061289
Mit CareLit weiterarbeiten